In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Liometacen Drug Master File in Korea (Liometacen KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Liometacen. The MFDS reviews the Liometacen KDMF as part of the drug registration process and uses the information provided in the Liometacen KDMF to evaluate the safety and efficacy of the drug.
After submitting a Liometacen KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Liometacen API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Liometacen suppliers with KDMF on PharmaCompass.